Liu Wenchao Selected Research

Carcinogenesis

1/2014

The mTOR inhibitor rapamycin synergizes with a fatty acid synthase inhibitor to induce cytotoxicity in ER/HER2-positive breast cancer cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Liu Wenchao Research Topics

Disease

1	Bone Neoplasms (Bone Cancer) 01/2016
1	Pain (Aches) 01/2016
1	Breast Neoplasms (Breast Cancer) 01/2014
1	Carcinogenesis 01/2014

Drug/Important Bio-Agent (IBA)

1	Morphine (MS Contin)FDA LinkGeneric 01/2016
1	TabletsIBA 01/2016
1	Diphosphonates (Bisphosphonates)IBA 01/2016
1	CeruleninIBA 01/2014
1	Selective Estrogen Receptor Modulators (SERM)IBA 01/2014
1	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2014
1	Sirolimus (Rapamycin)FDA Link 01/2014

Therapy/Procedure

1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2016
1	Radiotherapy 01/2016
1	Therapeutics 01/2016